February 27, 2004
Ecstasy Agonistes
A retracted study on a controversial substance raises questions about the reliability of government-sponsored research on drugsColloquy Live: Read the transcript of a live, online discussion with Rick Doblin, president of the Multidisciplinary Association for Psychedelic Studies, about research on the drug Ecstasy and whether its dangers have been overstated for political reasons.
Timeline: Key Moments in Ecstasy ResearchBy THOMAS BARTLETT
Until recently, Ecstasy had been
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
